# A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)

> **NCT02478008** · NA · TERMINATED · sponsor: **Edwards Lifesciences** · enrollment: 2 (actual)

## Conditions studied

- Mitral Insufficiency
- Heart Valve Disease
- Cardiovascular Disease
- Heart Disease

## Interventions

- **DEVICE:** CardiAQ TMVI System (Transapical DS)

## Key facts

- **NCT ID:** NCT02478008
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Edwards acquired CardiAQ and opted to terminate this study. 2 patients were enrolled and follow-up is complete. No further enrollment or follow-up will occur.
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478008, "A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02478008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*